Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$34.42−1.49 (-4.15%)
Close on Nov 18, 2026Market cap $1.18BP/E –Yield –
Nektar Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Nektar Therapeutics's pe ratio was 8.1× on Jul 31, 2019, against 395.7× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jul 31, 2019 | 8.1× | −0.2 |
| 2018 | Dec 31, 2018 | 8.3× | −387.4 |
| 2015 | Oct 30, 2015 | 395.7× | – |
See a number that looks wrong?